Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation: Heart Failure

• Publication date

  2015-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.114.001677PMID 25394648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.

  2014cited by this paper
• Fibrosis and heart failure

  2014cited by this paper
• Diastolic function is associated with quality of life and exercise capacity in stable heart failure patients with reduced ejection fraction

  2013cited by this paper
• Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy

  2013cited by this paper
• Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure.

  2013cited by this paper
• Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

  2013cited by this paper
• Effects of exercise interventions on peripheral vascular endothelial vasoreactivity in patients with heart failure with reduced ejection fraction.

  2013cited by this paper
• Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload.

  2013cited by this paper
• Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery.

  2013cited by this paper
• Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions.

  2013cited by this paper
• Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.

  2013cited by this paper
• Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.

  2013cited by this paper
• Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*

  2012cited by this paper
• Unraveling new mechanisms of exercise intolerance in chronic heart failure. Role of exercise training

  2012cited by this paper
• Abstract 16900: Global Proteomics and Pathway Analysis of Pressure-Overload Induced Heart Failure And Its Attenuation by Mitochondrial Targeted Peptides

  2012cited by this paper
• Endothelial dysfunction, arterial stiffness, and heart failure.

  2012cited by this paper
• Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats

  2012cited by this paper
• No rest for the weary: diastolic calcium homeostasis in the normal and failing myocardium.

  2012cited by this paper
• Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure

  2011cited by this paper
• Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?

  2011cited by this paper
• Myocardial ATGL Overexpression Decreases the Reliance on Fatty Acid Oxidation and Protects against Pressure Overload-Induced Cardiac Dysfunction

  2011cited by this paper
• Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction

  2011cited by this paper
• Continued Postnatal Administration of Resveratrol Prevents Diet-Induced Metabolic Syndrome in Rat Offspring Born Growth Restricted

  2011cited by this paper
• Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

  2011cited by this paper
• Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.

  2011cited by this paper
• Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat

  2011cited by this paper
• Molecular pathways underlying cardiac remodeling during pathophysiological stimulation.

  2010cited by this paper
• Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction

  2010cited by this paper
• Alterations in Skeletal Muscle Fatty Acid Handling Predisposes Middle-Aged Mice to Diet-Induced Insulin Resistance

  2010cited by this paper
• Effects of aerobic or aerobic and resistance training on cardiorespiratory and skeletal muscle function in heart failure: a randomized controlled pilot trial

  2009cited by this paper
• Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1

  2009cited by this paper
• Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study.

  2009cited by this paper
• Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure.

  2009cited by this paper
• Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta‐analysis of longitudinal data (MeRGE Heart Failure)

  2009cited by this paper
• Small animal models of heart failure: development of novel therapies, past and present.

  2009cited by this paper
• Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: An individual patient meta‐analysis

  2008cited by this paper
• Contribution of systolic and diastolic abnormalities to heart failure with a normal and a reduced ejection fraction.

  2007cited by this paper
• Chronic Resveratrol Enhances Endothelium-Dependent Relaxation but Does Not Alter eNOS Levels in Aorta of Spontaneously Hypertensive Rats

  2007cited by this paper
• Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.

  2006cited by this paper
• Targeted Deletion of Matrix Metalloproteinase 2 Ameliorates Myocardial Remodeling in Mice With Chronic Pressure Overload

  2006cited by this paper
• Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.

  2005cited by this paper
• Regression of pressure overload-induced left ventricular hypertrophy in mice.

  2005cited by this paper
• Healing after myocardial infarction.

  2005cited by this paper
• Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy

  2005cited by this paper
• Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor.

  2005cited by this paper
• Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.

  2004cited by this paper
• Cardiac hypertrophy: the good, the bad, and the ugly.

  2003cited by this paper
• Vascular dysfunction and heart failure: epiphenomenon or etiologic agent?

  2002cited by this paper
• Abnormal mitochondrial respiration in failed human myocardium.

  2000cited by this paper
• Contribution of glycogen to aerobic myocardial glucose utilization.

  1996cited by this paper
• Total-body and myocardial substrate oxidation in congestive heart failure.

  1994cited by this paper
• Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure

  1992cited by this paper
• Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts.

  1991cited by this paper
• Hemodynamic determinants of exercise capacity in chronic heart failure.

  1991cited by this paper
• Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

  1981cited by this paper

• Polyphenols as Adjuvant Treatment for Heart Failure with Preserved Ejection Fraction (HFpEF): A Review

  2026cites this paper
• Metabo-epigenetic circuits of heart failure: chromatin-modifying enzymes as determinants of metabolic plasticity

  2025cites this paper
• Plant Polyphenols as Heart’s Best Friends: From Health Properties, to Cellular Effects, to Molecular Mechanisms of Action

  2025cites this paper
• Sirtuins regulate macrophage polarization in heart failure: Metabolic reprogramming, epigenetic regulation, and immune cell interactions.

  2025cites this paper
• Arsenic-induced neurocardiac toxicity and protective role of Resveratrol: histopathological and molecular insights

  2025cites this paper
• Impact of plant-derived antioxidants on heart aging: a mechanistic outlook

  2025cites this paper
• From Plants to Protection: Cardiorenal Benefits in Non-Diabetic Chronic Kidney Disease and Heart Failure

  2025cites this paper
• Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential.

  2024cites this paper
• Investigating the Molecular Mechanisms of Resveratrol in Treating Cardiometabolic Multimorbidity: A Network Pharmacology and Bioinformatics Approach with Molecular Docking Validation

  2024cites this paper
• The role of pyroptosis in heart failure and related traditional chinese medicine treatments

  2024cites this paper
• Energy metabolism and redox balance: How phytochemicals influence heart failure treatment.

  2024cites this paper
• Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms

  2023influential citation
• Identification of key genes associated with heart failure based on bioinformatics analysis and screening of traditional Chinese medicines for the prevention and treatment of heart failure

  2023cites this paper
• Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review

  2023cites this paper
• Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

  2023cites this paper
• Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.

  2023cites this paper
• Effects of resveratrol supplementation on cardiac remodeling in hypertensive patients: a randomized controlled clinical trial

  2023cites this paper
• The Use of Dietary Supplements and Amino Acid Restriction Interventions to Reduce Frailty in Pre-Clinical Models

  2022cites this paper
• Branched-Chain Amino Acid Metabolism in the Failing Heart

  2022cites this paper
• Impact of Diet on Gut Microbiota Composition and Microbiota-Associated Functions in Heart Failure: A Systematic Review of In Vivo Animal Studies

  2022cites this paper
• Interactive Effects of Swimming High-Intensity Interval Training and Resveratrol Supplementation Improve Mitochondrial Protein Levels in the Hippocampus of Aged Rats

  2022cites this paper
• AMPK/Sirt1-mediated inflammation is positively correlated with myocardial fibrosis during ageing

  2022cites this paper
• Scleraxis and fibrosis in the pressure-overloaded heart.

  2022cites this paper
• Mitochondrial derived peptide MOTS‐c prevents the development of heart failure under pressure overload conditions in mice

  2022cites this paper
• Role of resveratrol in inhibiting pathological cardiac remodeling

  2022cites this paper
• Animal Models of Dysregulated Cardiac Metabolism

  2022cites this paper
• Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins

  2021cites this paper
• Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model

  2021cites this paper
• Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heart

  2021cites this paper
• The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results

  2021cites this paper
• Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension

  2021cites this paper
• Resveratrol and endothelial function: a literature review.

  2021cites this paper
• Resveratrol improves cardiac function and left ventricular fibrosis after myocardial infarction in rats by inhibiting NLRP3 inflammasome activity and the TGF-β1/SMAD2 signaling pathway

  2021cites this paper
• Cardiac Energy Metabolism in Heart Failure

  2021cites this paper
• Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability

  2021cites this paper
• Resveratrol and cardiac fibrosis prevention and treatment.

  2021cites this paper
• Modulatory Effects of Chinese Herbal Medicines on Energy Metabolism in Ischemic Heart Diseases

  2020cites this paper
• Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure

  2020cites this paper
• The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

  2020cites this paper
• Genomic characterization reveals novel mechanisms underlying the valosin-containing protein-mediated cardiac protection against heart failure

  2020cites this paper
• Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation

  2020cites this paper
• Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease

  2020cites this paper
• Oxidative Stress in Cardiovascular Diseases

  2020cites this paper
• Caloric restriction mimetics for the treatment of cardiovascular diseases.

  2020cites this paper
• Energy metabolism disorders and potential therapeutic drugs in heart failure

  2020cites this paper
• Novel pharmacotherapies for heart failure

  2020cites this paper
• Analysis of lncRNA-miRNA-mRNA Expression Pattern in Heart Tissue After Total Body Irradiation in a Mouse Model

  2020cites this paper
• The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review

  2019cites this paper
• Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease

  2019cites this paper
• Novel Concepts in Cardiac Energy Metabolism: From Biology to Disease

  2019cites this paper
• Resveratrol Attenuates Pressure Overload-Induced Cardiac fibrosis and Diastolic Dysfunction via PTEN/AKT/Smad2/3 and NF-κB Signaling Pathways.

  2019cites this paper
• Cardiac manifestations of inherited metabolic disease linked to cellular metabolism of vitamin B12 : study in two murine models of invalidation of Mtr and MMACHC genes

  2019cites this paper
• Resveratrol improves left ventricular remodeling in chronic kidney disease via Sirt1-mediated regulation of FoxO1 activity and MnSOD expression.

  2019cites this paper
• Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains

  2019cites this paper
• Potential application of resveratrol in nanocarriers against cancer: Overview and future trends

  2019cites this paper
• Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure

  2018cites this paper
• Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling

  2018cites this paper
• Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase.

  2018cites this paper
• Loss of Metabolic Flexibility in the Failing Heart

  2018cites this paper
• Therapeutic Potential of Polyphenols in Cardiac Fibrosis

  2018cites this paper
• Herbal Intervention in Cardiovascular Diseases

  2018cites this paper
• Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling

  2018cites this paper
• Natural Products as a Source for Antifibrosis Therapy.

  2018cites this paper
• The Blueprint for Retarding and Reversing Cardiovascular Aging

  2018cites this paper
• Icariside II attenuates cardiac remodeling via AMPKα2/mTORC1 in vivo and in vitro.

  2018cites this paper
• Postnatal resveratrol supplementation improves cardiovascular function in male and female intrauterine growth restricted offspring

  2017influential citation
• Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy

  2017cites this paper
• Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor.

  2017cites this paper
• Resveratrol pre- and post-treatment in doxorubicin-induced cardiac injury in relation to endogenous stem cell activation

  2017cites this paper
• Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure

  2017influential citation
• Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.

  2017cites this paper
• A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy.

  2017cites this paper
• Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.

  2017influential citation
• Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro

  2017cites this paper
• Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.

  2017cites this paper
• Resveratrol: An Epigenetic Regulator of SIRT1 – Is It a Magic Tool to Prevent Cardiovascular Disease?

  2017cites this paper
• Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes.

  2017cites this paper
• Inhibition of Cardiomyocytes Hypertrophy by Resveratrol Is Associated with Amelioration of Endoplasmic Reticulum Stress

  2016cites this paper
• AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.

  2016cites this paper
• Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.

  2016cites this paper
• Resveratrol Ameliorates Cardiac Hypertrophy by Down‐regulation of miR‐155 Through Activation of Breast Cancer Type 1 Susceptibility Protein

  2016cites this paper
• Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.

  2016cites this paper
• Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.

  2016cites this paper
• Staying young at heart: autophagy and adaptation to cardiac aging.

  2016cites this paper
• The Future of Heart Failure Diagnosis, Therapy, and Management.

  2016cites this paper
• Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.

  2016cites this paper
• Impact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients

  2016cites this paper
• Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art

  2015cites this paper
• Resveratrol Attenuated Low Ambient Temperature-Induced Myocardial Hypertrophy via Inhibiting Cardiomyocyte Apoptosis

  2015cites this paper
• Therapeutic potential of resveratrol in heart failure

  2015cites this paper
• Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy

  2015cites this paper
• Resveratrol Ameliorates Pressure Overload–induced Cardiac Dysfunction and Attenuates Autophagy in Rats

  2015cites this paper
• Resveratrol and derivatives for the treatment of atrial fibrillation

  2015cites this paper